These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33483965)

  • 41. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.
    Alexander C; Elliott C; Valentine J; Stannage K; Bear N; Donnelly CJ; Shipman P; Reid S
    Dev Med Child Neurol; 2018 Nov; 60(11):1165-1171. PubMed ID: 30151852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study.
    Baricich A; Picelli A; Carda S; Smania N; Cisari C; Santamato A; de Sire A; Invernizzi M
    Ann Phys Rehabil Med; 2019 Jul; 62(4):214-219. PubMed ID: 31228593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY; Jung S; Rha DW; Park ES
    Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum neurotoxin type A responders among children with spastic cerebral palsy: Pattern-specific effects.
    Papageorgiou E; Peeters N; Staut L; Molenaers G; Ortibus E; Van Campenhout A; Desloovere K
    Eur J Paediatr Neurol; 2024 Mar; 49():131-140. PubMed ID: 38518417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy.
    Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):41-7. PubMed ID: 22580859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum Toxin in the Management of Children with Cerebral Palsy.
    Multani I; Manji J; Hastings-Ison T; Khot A; Graham K
    Paediatr Drugs; 2019 Aug; 21(4):261-281. PubMed ID: 31257556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity impairments in unilateral Cerebral Palsy: an explorative study.
    Speth L; Janssen-Potten Y; Leffers P; Rameckers E; Defesche A; Winkens B; Becher J; Smeets R; Vles JS
    Eur J Paediatr Neurol; 2015 May; 19(3):337-48. PubMed ID: 25661064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004; (3):CD003469. PubMed ID: 15266487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures.
    Desloovere K; Molenaers G; Jonkers I; De Cat J; De Borre L; Nijs J; Eyssen M; Pauwels P; De Cock P
    Eur J Neurol; 2001 Nov; 8 Suppl 5():75-87. PubMed ID: 11851736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
    Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
    Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
    Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
    Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy.
    Flett PJ; Stern LM; Waddy H; Connell TM; Seeger JD; Gibson SK
    J Paediatr Child Health; 1999 Feb; 35(1):71-7. PubMed ID: 10234640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial.
    Hoare B; Imms C; Villanueva E; Rawicki HB; Matyas T; Carey L
    Dev Med Child Neurol; 2013 Mar; 55(3):238-47. PubMed ID: 23236956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
    Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrical Stimulation Following Botulinum Toxin A in Children With Spastic Diplegia: A Within-Participant Randomized Pilot Study.
    Mudge A; Harvey LA; Lancaster A; Lowe K
    Phys Occup Ther Pediatr; 2015; 35(4):342-53. PubMed ID: 25529410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin-A with and without rehabilitation for the treatment of spastic cerebral palsy.
    Jianjun L; Shurong J; Weihong W; Yan Z; Fanyong Z; Nanling L
    J Int Med Res; 2013 Jun; 41(3):636-41. PubMed ID: 23696596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
    Schasfoort F; Pangalila R; Sneekes EM; Catsman C; Becher J; Horemans H; Stam HJ; Dallmeijer AJ; Bussmann JBJ
    J Rehabil Med; 2018 Aug; 50(8):732-742. PubMed ID: 30080235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.
    Thorley M; Donaghey S; Edwards P; Copeland L; Kentish M; McLennan K; Lindsley J; Gascoigne-Pees L; Sakzewski L; Boyd RN
    BMC Pediatr; 2012 Aug; 12():120. PubMed ID: 22873758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.